<< Back
Oct 13, 2015

Tandem Diabetes Care Schedules Third Quarter 2015 Earnings Press Release and Conference Call

SAN DIEGO, Oct. 13, 2015 (GLOBE NEWSWIRE) -- Tandem Diabetes Care®, Inc. (NASDAQ:TNDM), a medical device company and manufacturer of the t:slim®, t:flex®  and t:slim G4 Insulin Pumps, plans to release its third quarter 2015 results after the financial markets close on Thursday, October 29, 2015.  The Company will hold a conference call and simultaneous webcast on the same day at 4:30pm Eastern Time (1:30pm Pacific Time), to discuss its third quarter 2015 financial and operating results. 

Conference Call/Webcast Details:
Date: October 29, 2015
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 54342520
Webcast Link: http://edge.media-server.com/m/p/f3gpecju

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com in the "Investor Events" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslim, #tflex, #tslimG4, #tconnect and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.

t:slim, t:flex, and Tandem Diabetes Care are registered trademarks, and t:slim G4 is a trademark of Tandem Diabetes Care, Inc.

Media Contact:

Steve Sabicer



Investor Contact:

Susan Morrison

858-366-6900 x7005


Primary Logo

Source: Tandem Diabetes Care, Inc

News Provided by Acquire Media